Iron Deficiency: A Global Health Crisis in Plain Sight
Swiss Pharmaceuticals Pvt. Ltd. Karachi Pakistan
“To manufacture and market quality medicine at affordable prices”.
Many today believe that crises come in the form of financial instability or economic downfall, but the truth is they often begin with health.
Iron deficiency is a silent yet widespread issue that weakens millions, decreases productivity, and creates a ripple effect that affects not just individuals but also families, communities, and the economy.
Globally, Anemia affects over 1.24 billion individuals, with the frequency varying significantly across regions. In Africa, the prevalence of anemia can reach 64.6%, while in Asia, it is about 47.7%. In contrast, North America reports much lower rates, around 3.4%.
The World Health Organization estimates that about 30% of the world population suffers from iron deficiency.
Children and women are in particular vulnerable. In 2019, it was reported that 39.8% of children aged 6-59 months were anemic, translating into 269 million children globally affected by this condition.
Iron Deficiency in Pakistan
Pakistan is not far behind in iron deficiency anemia leading to a critical public health issue. The statistics indicate:
The cause of iron deficiency is multifaceted, involving several socio-economic and dietary factors:
Swiss Pharmaceutical is committed to delivering comprehensive health and disease-related information to its audience. It is driven by the belief that a healthy population is the foundation of a thriving economy. By empowering individuals with knowledge, Swiss Pharmaceutical aims to foster well-being, productivity, and sustainable development for all.
References: